ROTHSTEIN, B. Topical JAK inhibitor Ruxolitinib for Vitiligo Treatment. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 2, p. S110-S111, 2018. DOI: 10.25251/skin.2.supp.102. Disponível em: https://jofskin.org/33014/index.php/skin/article/view/451. Acesso em: 22 jul. 2024.